Pharmacological Microglial Inhibition Remodels the Scar Microenvironment to Support Reticulospinal Circuit

Run Li1, Hongyuan Xing1, Yifan Shen1

  • 1Department of Orthopedic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.

Summary

Early treatment with a beta-2 adrenergic receptor agonist promotes microglial transition to a homeostatic state, aiding spinal cord injury repair. This approach reduces scar inhibition, promotes axonal regrowth, and restores motor function by modulating glial-neural circuits.